These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18452176)

  • 21. Recent Advances in Encapsulation, Protection, and Oral Delivery of Bioactive Proteins and Peptides using Colloidal Systems.
    Perry SL; McClements DJ
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32150848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclodextrin based nanosponges for pharmaceutical use: a review.
    Tejashri G; Amrita B; Darshana J
    Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery.
    Ferderber K; Hook S; Rades T
    J Liposome Res; 2009; 19(4):267-77. PubMed ID: 19863162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid vesicles and other colloids as drug carriers on the skin.
    Cevc G
    Adv Drug Deliv Rev; 2004 Mar; 56(5):675-711. PubMed ID: 15019752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical appraisal of microemulsions for drug delivery: part II.
    Sapra B; Thatai P; Bhandari S; Sood J; Jindal M; Tiwary AK
    Ther Deliv; 2014 Jan; 5(1):83-94. PubMed ID: 24341819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems.
    Kuntsche J; Horst JC; Bunjes H
    Int J Pharm; 2011 Sep; 417(1-2):120-37. PubMed ID: 21310225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery.
    Mainardes RM; Urban MC; Cinto PO; Chaud MV; Evangelista RC; Gremião MP
    Curr Drug Deliv; 2006 Jul; 3(3):275-85. PubMed ID: 16848729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the use of novel drug delivery systems for antiretroviral drugs.
    Ojewole E; Mackraj I; Naidoo P; Govender T
    Eur J Pharm Biopharm; 2008 Nov; 70(3):697-710. PubMed ID: 18655830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystals and crystallization in oil-in-water emulsions: implications for emulsion-based delivery systems.
    McClements DJ
    Adv Colloid Interface Sci; 2012 Jun; 174():1-30. PubMed ID: 22475330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colloidal systems for drug delivery: from design to therapy.
    Beija M; Salvayre R; Lauth-de Viguerie N; Marty JD
    Trends Biotechnol; 2012 Sep; 30(9):485-96. PubMed ID: 22673692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.
    He CX; He ZG; Gao JQ
    Expert Opin Drug Deliv; 2010 Apr; 7(4):445-60. PubMed ID: 20201713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentials of new nanocarriers for dermal and transdermal drug delivery.
    Neubert RH
    Eur J Pharm Biopharm; 2011 Jan; 77(1):1-2. PubMed ID: 21111043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supramolecular approaches for drug development.
    Kawakami K; Ebara M; Izawa H; Sanchez-Ballester NM; Hill JP; Ariga K
    Curr Med Chem; 2012; 19(15):2388-98. PubMed ID: 22455591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chapter 3 - Colloidal systems for CNS drug delivery.
    Costantino L; Tosi G; Ruozi B; Bondioli L; Vandelli MA; Forni F
    Prog Brain Res; 2009; 180():35-69. PubMed ID: 20302828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons.
    Bagwe RP; Kanicky JR; Palla BJ; Patanjali PK; Shah DO
    Crit Rev Ther Drug Carrier Syst; 2001; 18(1):77-140. PubMed ID: 11326744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow.
    Moghimi SM; Illum L; Davis SS
    Crit Rev Ther Drug Carrier Syst; 1990; 7(3):187-209. PubMed ID: 2073686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I.
    Abdel-Mottaleb MM; Lamprecht A
    Drug Dev Ind Pharm; 2011 Feb; 37(2):178-84. PubMed ID: 21073322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug release from liquisolid systems: speed it up, slow it down.
    Nokhodchi A; Hentzschel CM; Leopold CS
    Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.